This is a preview of subscription content, log in via an institution to check access.
Notes
HMG-CoA reductase inhibitor
Reference
Kodera S, et al. Cost-Effectiveness of Statin Plus Eicosapentaenoic Acid Combination Therapy for Cardiovascular Disease Prevention in Japanese Patients With Hypercholesterolemia- An Analysis Based on the Japan Eicosapentaenoic Acid Lipid Intervention Study (JELIS). Circulation Journal : 23 Jan 2018. Available from: URL: http://doi.org/10.1253/circj.CJ-17-0995
Rights and permissions
About this article
Cite this article
EPA plus statin cost effective for secondary prevention of CVD. PharmacoEcon Outcomes News 796, 15 (2018). https://doi.org/10.1007/s40274-018-4689-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4689-5